PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1755385
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1755385
U.S. Veterinary Surgical Instruments Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
U.S. Veterinary Surgical Instruments Market was valued at USD 625.2 million in 2034 and is estimated to grow at a CAGR of 6.6% to reach USD 1.2 billion by 2034, driven by the increasing population of both pets and livestock, combined with rising expenditures on veterinary care and services. The demand for effective treatments, such as surgeries for chronic conditions like arthritis, cancer, and cardiovascular issues in animals, is contributing to this market expansion. As more veterinary clinics and hospitals become accessible, the use of advanced surgical treatments for animals is also on the rise, further driving the need for specialized surgical instruments.
Moreover, the increasing acceptance and adoption of pet insurance are significantly contributing to the growth of the veterinary surgical instruments market. Pet insurance offers pet owners a valuable financial tool, allowing them to more easily afford high-quality veterinary services. With the ability to cover a broader range of treatments, including surgeries, pet owners are more likely to opt for advanced care for their animals, which, in turn, drives up the demand for surgical instruments. This trend is especially relevant as owners are becoming more conscious of their pets' health, often seeking cutting-edge treatments that were previously out of reach due to cost concerns. Pet insurance effectively reduces out-of-pocket expenses, enabling pet owners to pursue optimal care options without financial strain, and thus propelling the demand for specialized surgical equipment.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $625.2 Million |
| Forecast Value | $1.2 Billion |
| CAGR | 6.6% |
In 2024, the electro-surgery instruments segment generated t USD 175.7 million attributed to the growing preference for electro-surgical instruments in veterinary procedures due to their precision and effectiveness. Unlike traditional surgical tools, electrosurgical instruments minimize blood loss, improve operational efficiency, and reduce post-operative swelling. Their ability to deliver controlled energy during procedures enhances safety and provides better patient outcomes. The integration of these instruments with advanced digital systems, such as electrosurgical generators with touchscreen interfaces, further improves the accuracy and control of surgeries, increasing their appeal in veterinary practices.
The companion animal segment maintained its lead in the market with 61.3% share in 2024, driven by a rising number of pet owners and an increasing willingness to invest in quality healthcare for pets. The demand for veterinary surgeries has escalated as pets are considered integral members of many households. The growing trend of pet humanization-where pets are seen as family members rather than animals-has led to higher expectations for their medical care. With more pet owners seeking preventative treatments and surgical interventions, this segment is poised for sustained growth.
Florida Veterinary Surgical Instruments Market generated USD 44.9 million in 2024 due to its large pet population and well-developed veterinary infrastructure. Florida, being the third most populous state in the U.S., is home to a significant number of pet owners, which translates into a high demand for veterinary services, including surgical treatments. The state's strong focus on animal welfare and extensive veterinary education programs further bolster its position, making it a hub for advanced veterinary care and surgical innovations. The state's large market for pet care services directly impacts the demand for surgical instruments, reinforcing its leading role in the market.
Key players in the U.S. Veterinary Surgical Instruments Market include Neogen Corporation, Ethicon, Arthrex, STERIS, and Jorgensen Laboratories. Companies in the U.S. veterinary surgical instruments market are adopting several strategies to maintain a competitive edge. These include enhancing their product offerings by incorporating advanced technologies like electrosurgical devices with integrated digital systems, ensuring greater precision during surgeries. Additionally, leading companies are investing in robust research and development to develop more efficient and specialized surgical instruments. Strategic partnerships and collaborations with veterinary clinics and hospitals help improve product accessibility and adoption, while mergers and acquisitions strengthen market presence.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing animal healthcare expenditure
- 3.2.1.2 Rising awareness about various animal health conditions
- 3.2.1.3 High adoption of pet health insurance
- 3.2.1.4 Growth in the number of veterinary practitioners
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost of veterinary surgeries
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Pricing analysis
- 3.6 Technology landscape
- 3.7 Future market trends
- 3.8 Trump administration tariffs
- 3.8.1 Impact on trade
- 3.8.1.1 Trade volume disruptions
- 3.8.1.2 Retaliatory measures
- 3.8.2 Impact on the industry
- 3.8.2.1 Supply-side impact
- 3.8.2.1.1 Price volatility in key materials
- 3.8.2.1.2 Supply chain restructuring
- 3.8.2.1.3 Production cost implications
- 3.8.2.2 Demand-side impact (selling price)
- 3.8.2.2.1 Price transmission to end markets
- 3.8.2.2.2 Market share dynamics
- 3.8.2.2.3 Consumer response patterns
- 3.8.2.1 Supply-side impact
- 3.8.3 Key companies impacted
- 3.8.4 Strategic industry responses
- 3.8.4.1 Supply chain reconfiguration
- 3.8.4.2 Pricing and product strategies
- 3.8.4.3 Policy engagement
- 3.8.5 Outlook and future considerations
- 3.8.1 Impact on trade
- 3.9 Porter's analysis
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
- 5.1 Key trends
- 5.2 Sutures and staplers
- 5.3 Forceps
- 5.4 Scalpels
- 5.5 Surgical scissors
- 5.6 Hooks and retractors
- 5.7 Trocars and cannulas
- 5.8 Electro-surgery instruments
- 5.9 Other products
Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)
- 6.1 Key trends
- 6.2 Companion animals
- 6.2.1 Dogs
- 6.2.2 Cats
- 6.2.3 Horses
- 6.2.4 Other companion animals
- 6.3 Livestock animals
- 6.3.1 Cattle
- 6.3.2 Sheep and goats
- 6.3.3 Swine
- 6.3.4 Poultry
- 6.4 Exotic and zoo animals
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
- 7.1 Key trends
- 7.2 Soft tissue surgery
- 7.3 Sterilization surgery
- 7.4 Dental surgery
- 7.5 Orthopedic surgery
- 7.6 Ophthalmic surgery
- 7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
- 8.1 Key trends
- 8.2 Veterinary hospitals
- 8.3 Veterinary clinics
- 8.4 Academic and research institutes
- 8.5 Other end use
Chapter 9 Market Estimates and Forecast, By Zone, 2021 – 2034 ($ Mn)
- 9.1 Key trends
- 9.2 North East
- 9.2.1 Connecticut
- 9.2.2 Maine
- 9.2.3 Massachusetts
- 9.2.4 New Hampshire
- 9.2.5 Rhode Island
- 9.2.6 Vermont
- 9.2.7 New Jersey
- 9.2.8 New York
- 9.2.9 Pennsylvania
- 9.3 East North Central
- 9.3.1 Wisconsin
- 9.3.2 Michigan
- 9.3.3 Illinois
- 9.3.4 Indiana
- 9.3.5 Ohio
- 9.4 West North Central
- 9.4.1 North Dakota
- 9.4.2 South Dakota
- 9.4.3 Nebraska
- 9.4.4 Kansas
- 9.4.5 Minnesota
- 9.4.6 Iowa
- 9.4.7 Missouri
- 9.5 South Atlantic
- 9.5.1 Delaware
- 9.5.2 Maryland
- 9.5.3 District of Columbia
- 9.5.4 Virginia
- 9.5.5 West Virginia
- 9.5.6 North Carolina
- 9.5.7 South Carolina
- 9.5.8 Georgia
- 9.5.9 Florida
- 9.6 East South Central
- 9.6.1 Kentucky
- 9.6.2 Tennessee
- 9.6.3 Mississippi
- 9.6.4 Alabama
- 9.7 West South Central
- 9.7.1 Oklahoma
- 9.7.2 Texas
- 9.7.3 Arkansas
- 9.7.4 Louisiana
- 9.8 Mountain States
- 9.8.1 Idaho
- 9.8.2 Montana
- 9.8.3 Wyoming
- 9.8.4 Nevada
- 9.8.5 Utah
- 9.8.6 Colorado
- 9.8.7 Arizona
- 9.8.8 New Mexico
- 9.9 Pacific Central
- 9.9.1 California
- 9.9.2 Alaska
- 9.9.3 Hawaii
- 9.9.4 Oregon
- 9.9.5 Washington
Chapter 10 Company Profiles
- 10.1 Arthrex
- 10.2 Avante Animal Health (Avante Health Solutions)
- 10.3 B. Braun Vet Care
- 10.4 BMT Medizintechnik
- 10.5 Ethicon (Johnson & Johnson)
- 10.6 GerMedUSA
- 10.7 Integra LifeSciences
- 10.8 Jorgensen Laboratories
- 10.9 Jørgen Kruuse (Henry Schein)
- 10.10 Medtronic
- 10.11 Neogen Corporation
- 10.12 Sklar Instruments
- 10.13 STERIS
- 10.14 Surgical Holdings
- 10.15 Smiths Medical
- 10.16 Vimian Group
